معرفی
Prof. Dr. Bernd Neumaier serves as Professor and Head of the Nuclear Chemistry department (INM-5) at the Institute of Neuroscience and Medicine, Jülich Research Centre. His leadership drives interdisciplinary research at the intersection of nuclear science, neuroscience, and clinical medicine within one of Europe's premier Helmholtz Association research facilities.
His research focuses on Nuclear Chemistry, Radiopharmaceutical Chemistry, Molecular Imaging, Radiochemistry, and Nuclear Medicine. These fields center on developing novel radiotracers for positron emission tomography (PET) and other imaging modalities to study brain function, neurological disorders, and cancer progression. His work integrates radiochemistry with molecular biology to create targeted diagnostic and therapeutic agents that advance precision medicine.
No scientific awards were documented in the source material.
Information regarding academic advising relationships or specific research grants was not provided in the available documentation.
As head of the Nuclear Chemistry department (INM-5), Prof. Neumaier leads a specialized research group within the Institute of Neuroscience and Medicine. The department operates from Building 15.19/Room 4011 at Jülich Research Centre, maintaining state-of-the-art radiochemistry laboratories for synthesizing and characterizing radiopharmaceuticals. The team collaborates extensively with clinical partners to translate fundamental discoveries into medical applications, particularly in neuroimaging and oncology.
